These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38697893)
1. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer. Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC Med Clin (Barc); 2024 Aug; 163(4):159-166. PubMed ID: 38697893 [TBL] [Abstract][Full Text] [Related]
2. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5. Sadek SA; A Rehim DM; Fatima S Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes. Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973 [TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma. Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202 [TBL] [Abstract][Full Text] [Related]
6. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer. Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system. Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430 [TBL] [Abstract][Full Text] [Related]
8. Tumor Budding as a Prognostic Marker in Primary Colon Cancer - A Single Center Experience. Dukoska DB; Zdravkovski P; Kostadinova-Kunovska S; Krsteska B; Karagjozov P; Dzambaz D; Nikolovski A; Antovic S; Jankulovski N; Petrushevska G Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Jun; 45(2):47-58. PubMed ID: 39008643 [No Abstract] [Full Text] [Related]
9. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis. Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy. Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039 [TBL] [Abstract][Full Text] [Related]
11. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer. Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282 [TBL] [Abstract][Full Text] [Related]
12. Tumour budding - an additional prognostic factor in colorectal cancer survival. Kamall GH; Ulusoy C; Nikolovski A; Kamall S Pol J Pathol; 2023; 74(1):36-41. PubMed ID: 37306351 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and survival analysis of 837 Chinese colorectal cancer patients. Yuan Y; Li MD; Hu HG; Dong CX; Chen JQ; Li XF; Li JJ; Shen H World J Gastroenterol; 2013 May; 19(17):2650-9. PubMed ID: 23674872 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of perineural invasion in stages II and III colorectal cancer. Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129 [TBL] [Abstract][Full Text] [Related]
15. Correlations of pathomorphological parameters between lesions at the invasive front and lymph node metastases in colorectal cancer: a retrospective clinical study. Peng H; Zhang Z; Wu Y; Zhu Y J Egypt Natl Canc Inst; 2024 Jul; 36(1):23. PubMed ID: 38945978 [TBL] [Abstract][Full Text] [Related]
16. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior. Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750 [TBL] [Abstract][Full Text] [Related]
17. Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer. Gan T; Schaberg KB; He D; Mansour A; Kapoor H; Wang C; Evers BM; Bocklage TJ JAMA Netw Open; 2021 Apr; 4(4):e213897. PubMed ID: 33792733 [TBL] [Abstract][Full Text] [Related]
18. The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer. Hai ZX; Peng D; Li ZW; Liu F; Liu XR; Wang CY Sci Rep; 2024 Jul; 14(1):17689. PubMed ID: 39085386 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425 [TBL] [Abstract][Full Text] [Related]
20. Oncological Implications of Lymph Nodes Retrieval and Perineural Invasion in Colorectal Cancer: Outcomes from a Referral Center. Vergara-Fernandez O; Navarro-Navarro A; Rangel-Ríos HA; Salgado-Nesme N; Reyes-Monroy JA; Velázquez-Fernández D Rev Invest Clin; 2018; 70(6):291-300. PubMed ID: 30532087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]